As part of its program to establish a new medical school and its recently opened Institute for Personalized Medicine, Ariel University has now launched a Center for Drug Repurposing (CDR) in partnership with a private Israeli company, Drug Rediscovery Ltd. This is the world’s first academic center for drug re-purposing. Drug re-purposing is the process of formalizing a new use for an existing FDA-approved drug, typically one that is already “generic” (without patent protection). The CDR will incorporate a “Knowledge Center”, employing medical data-mining experts to populate a database known as Cureiosity®. This database builds connections between drugs, diseases and therapeutic targets in dimensions never applied before, and rapidly identifies new opportunities for drug re-purposing. At the core of its activities, the CDR will manage pre-clinical drug re-purposing development work at Ariel University.
For more information please visit CDR’s department page http://www.ariel.ac.il/research/cdr
To meet Israel’s critical shortage of physicians and other health professionals, Ariel University is focusing on the establishment of a medical school, aided by the generous support of the Adelson Family Foundation.
Students and faculty represent the large spectrum of Israeli society, including students from the orthodox and ultra-orthodox Jewish communities, Arab students and secular Jewish students.
Opened in 2014, the department has exclusive excavation rights to three unique and important archaeological sites dating back over 2,000 years to biblical times.
The Free Electron Laser Particle Accelerator at Ariel University is the only one of its kind in the Middle East. Scientists from all over Israel and the world take advantage of its unique attributes for technologically advanced research.